Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

DeNovo Ventures

Founders David M. Mauney Richard Ferrari

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 96
Average round size
info
The average size of a deal this fund participated in
$21M
Portfolio companies 39
Rounds per year 4.00
Lead investments 14
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.59
Exits 20
Key employees 4
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity

Areas of investment

  • Health Care
  • Medical Device
  • Biotechnology
  • Medical
  • Health Diagnostics
Summary

In 2000 was created DeNovo Ventures, which is appeared as VC. The main office of represented VC is situated in the Saratoga. The venture was found in North America in United States.

The top amount of exits for fund were in 2019. The real fund results show that this VC is 5 percentage points less often commits exit comparing to other companies. Comparing to the other companies, this DeNovo Ventures performs on 11 percentage points less the average number of lead investments. The important activity for fund was in 2007. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in 2-6 deals per year. When the investment is from DeNovo Ventures the average startup value is 100-500 millions dollars.

The fund was created by David M. Mauney, Richard Ferrari. We also calculated 4 valuable employees in our database.

For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the various public portfolio startups of the fund, we may underline EndoGastric Solutions, EBR Systems, TRIA Beauty Besides, a startup needs to be aged 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Medical, Biopharma. The fund has specific favorite in a number of founders of portfolio startups. If startup sums 3 or 5+ of the founder, the chance for it to be financed is low.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the DeNovo Ventures, startups are often financed by Advanced Technology Ventures, Delphi Ventures, Versant Ventures. The meaningful sponsors for the fund in investment in the same round are Versant Ventures, SV Health Investors, Prism Venture Management. In the next rounds fund is usually obtained by SV Health Investors, Johnson & Johnson Development Corporation, Foundation Medical Partners.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of DeNovo Ventures:
Typical Co-investors
DeNovo Ventures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after DeNovo Ventures:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Milo

Audio
Communication Hardware
Consumer Electronics
Information Technology
$12M08 Jan 2023 -

Astute Medical

Biotechnology
Health Care
Health Diagnostics
Medical
$40M07 Jun 2012 San Diego, California, United States

Viracta Therapeutics

Biopharma
Biotechnology
Medical
Pharmaceutical
Therapeutics
$13M12 Mar 2012 California, United States

Simpirica Spine

Health Care
Health Diagnostics
Therapeutics
$22M20 Sep 2011 California, United States

Benvenue Medical

Biotechnology
Health Care
Medical
Medical Device
$35M18 Apr 2011 San Jose, California, United States

Astute Medical

Biotechnology
Health Care
Health Diagnostics
Medical
$13M08 Mar 2011 San Diego, California, United States

Spiracur

Biotechnology
Health Care
Manufacturing
Medical Device
$35M01 Feb 2011 Redwood City, California, United States

Astute Medical

Biotechnology
Health Care
Health Diagnostics
Medical
$26M12 May 2010 San Diego, California, United States

TearScience

Biotechnology
Clinical Trials
Health Care
Medical
Medical Device
$44M06 May 2010 North Carolina, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent DeNovo Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 96
Average round size 21M
Rounds per year 4.00
Peak activity year 2007
Lead investments 14
Follow on index 0.59
Exits 20
Group Appearance index 0.96

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Milo

Audio
Communication Hardware
Consumer Electronics
Information Technology
$12M08 Jan 2023 -

Astute Medical

Biotechnology
Health Care
Health Diagnostics
Medical
$40M07 Jun 2012 San Diego, California, United States

Viracta Therapeutics

Biopharma
Biotechnology
Medical
Pharmaceutical
Therapeutics
$13M12 Mar 2012 California, United States

Simpirica Spine

Health Care
Health Diagnostics
Therapeutics
$22M20 Sep 2011 California, United States

Benvenue Medical

Biotechnology
Health Care
Medical
Medical Device
$35M18 Apr 2011 San Jose, California, United States

Astute Medical

Biotechnology
Health Care
Health Diagnostics
Medical
$13M08 Mar 2011 San Diego, California, United States

Spiracur

Biotechnology
Health Care
Manufacturing
Medical Device
$35M01 Feb 2011 Redwood City, California, United States

Astute Medical

Biotechnology
Health Care
Health Diagnostics
Medical
$26M12 May 2010 San Diego, California, United States

TearScience

Biotechnology
Clinical Trials
Health Care
Medical
Medical Device
$44M06 May 2010 North Carolina, United States
Crunchbase icon

Content report

The following text will be sent to our editors: